Immunosenescence and PFAS
Immunosenescence — the gradual deterioration of immune function with age — reduces the body’s ability to fight infections and respond to vaccines. PFAS accelerate immunosenescence through chronic immune activation that exhausts key immune cell populations, particularly naive T cells and memory B cells. The result is an immune profile in PFAS-exposed older adults resembling someone older than their chronological age.
PFAS-induced thymic atrophy — reduction in the thymus gland that produces T cells — may explain accelerated depletion of the naive T cell pool that is essential for responding to novel pathogens and newly formulated vaccines. An exhausted T cell pool provides inadequate defense against emerging infections, relevant in the context of pandemic preparedness.
Clinical Evidence
Studies comparing PFAS blood levels in adults over 65 find that higher PFAS levels correlate with lower lymphocyte counts, reduced NK cell cytotoxicity, and impaired neutrophil function — all markers of immune competence. These immune deficiencies correlate with clinical outcomes: higher PFAS levels in elderly adults predict higher rates of pneumonia, influenza-related hospitalization, and urinary tract infections.
Influenza and COVID-19 vaccine antibody responses in older adults with higher PFAS levels are significantly lower than in low-PFAS peers — raising the real-world concern that PFAS-contaminated communities face reduced herd immunity from vaccination programs, particularly in their most vulnerable elderly residents.
Protective Strategies for Older Adults
Elderly individuals in PFAS-contaminated communities have the most to gain from PFAS exposure reduction, and the most to lose from continued high exposure. Ensuring access to PFAS-free drinking water through certified filtration — whether provided by utilities, purchased individually, or provided through social services — is a priority health intervention for this population.
Primary care physicians managing elderly patients in contaminated areas should be alert to atypically low vaccine antibody titers, recurrent infections, and immune function test results inconsistent with expected age-related decline. These findings may warrant investigation of PFAS exposure and referral to environmental medicine specialists.